JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


First published online November 7, 2008, 10.2967/jnumed.108.053785
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JNM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Komar, G.
Right arrow Articles by Minn, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Komar, G.
Right arrow Articles by Minn, H.

18F-EF5: A New PET Tracer for Imaging Hypoxia in Head and Neck Cancer

Gaber Komar1, Marko Seppänen1, Olli Eskola1, Paula Lindholm2, Tove J. Grönroos1, Sarita Forsback1, Hannu Sipilä1, Sydney M. Evans3, Olof Solin1 and Heikki Minn1,2

1 Turku PET Centre, Turku, Finland; 2 Department of Oncology and Radiotherapy, University of Turku, Turku, Finland; and 3 Department of Radiation Oncology, School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania


Figure 1
View larger version (9K):
[in this window]
[in a new window]

 
FIGURE 1.  Time course for scanning protocol of combined 15O-H2O and 18F-EF5 study. CTAC = computer-assisted tomography for attenuation correction.

 

Figure 2
View larger version (31K):
[in this window]
[in a new window]

 
FIGURE 2.  (A) Combined blood flow and early and late (3 h from injection) 18F-EF5 images in patient 1, who presented with right T4N0 base-of-tongue HNSCC. Note similarity of blood flow and early 18F-EF5 images (2 min from injection), showing doughnutlike appearance of tracer uptake in tumor. By contrast, 18F-EF5 image obtained 3 h after injection shows uptake in central, less perfused area. (B) Time–activity curves from same tumor as in A, demonstrating differential uptake kinetics of 18F-EF5 of peripheral (nonhypoxic) and central (hypoxic) parts of tumor. In well-perfused area, initial uptake of 18F-EF5 is higher than that in more hypoxic area; after first 15 min, reverse is true. With exception of first 90-s image, uptake in dorsal neck muscle and arterial blood remain lower than that in both tumor parts throughout 3-h acquisition time.

 

Figure 3
View larger version (10K):
[in this window]
[in a new window]

 
FIGURE 3.  Maximum and mean 18F-EF5 T/M ratios over all static emission image acquisition time points. (A) Mean T/M ratios increase from 1 through 3 h after injection. (B) Higher maximum T/M ratio and lower mean T/M ratio at 4 h after injection, when compared with 3 h after injection, could be explained by increasing image noise (and decreasing overall image quality).

 

Figure 4
View larger version (44K):
[in this window]
[in a new window]

 
FIGURE 4.  Examples of both PET and CT images for all 3 tracers for 3 patients. 18F-EF5 images are made at 3 h after injection. Arrows indicate primary tumors, and arrowheads indicate metastatic lesions.

 

Figure 5
View larger version (23K):
[in this window]
[in a new window]

 
FIGURE 5.  Relationship between uptake of 18F-EF5 at 3 h expressed as T/M and blood flow on voxel-by-voxel basis in all 18 primary and metastatic tumors. y-Axis indicates threshold value of 1.5, tentatively representing PHA. x-Axis indicates perfusion value of 30 mL/100 g/min, which represents border between poorly and well-perfused areas. Resulting are areas of high perfusion with good oxygenation (trend A), low perfusion with low oxygenation (trend B), and intermediate perfusion (trend C).

 

Figure 6
View larger version (6K):
[in this window]
[in a new window]

 
FIGURE 6.  Comparison of percentages of tumor subvolumes representing PHA using 3 different T/M 18F-EF5 uptake threshold values. MATV is determined from 18F-FDG study performed on separate day.

 





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2008 by the Society of Nuclear Medicine.